| Application no. and date | 20811699.6 (espacenet) (Federated) (European Patent Register), 20201110 | | Patent/reg. no. and date | DK/EP 4058805, 20241002 | | Publication date | 20220921 | | Priority no. and date | FI 20195959, 20191111 | | EP pub. no. and date |
EP 4058805 20220921 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Joukahaisenkatu 6
20520 Turku, FI | | Applicant ref. no. | | | Inventor | HOLLMÉN, Maija-Leena, Rauvolantie 79
20760 Piispanristi, FI,
JALKANEN, Juho, Kaivattulantie 84
23120 Mietoinen, FI,
MANDELIN, Jami, Kuulijantie 28 B
00730 Helsinki, FI,
VIRTAKOIVU, Reetta, Luutnantintie 7
20810 TURKU, FI,
VAURA, Felix, Kahlaajankatu 1 D 3
20100 TURKU, FI | | Representative | | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE MARKERS ON LEUCOCYTES, AND USING THESE TO GUIDE ANTI-CLEVER-1 BASED CANCER TREATMENT | | Int. application no. | FI2020050741 | | Int. publication no. | WO2021094652 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
